The Future of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness

Cell and gene therapy manufacturing is evolving fast—and scaling successfully now requires more than just meeting regulatory expectations. It requires turning them into an advantage.

Our Panel will explore how leading CGT manufacturers are navigating cGMP complexity, harmonizing FDA and EMA requirements, and using digital tools to embed quality at the source—while scaling from batch-of-one to commercial production. The panel will also share practical guidance on building a paperless foundation, accelerating release times, and preparing for what digitally mature CGT operations will look like over the next five years.

If you’re involved in CGT manufacturing, quality, regulatory, or digital transformation, this is the event for you.